BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37417274)

  • 1. RECURRENT LENTIGO MALIGNA: CONSERVATIVE CONTINUOUS TREATMENT WITH IMIQUIMOD OR REPEATED SURGERY? A LONG-TERM FOLLOW-UP DERMOSCOPIC CASE STUDY.
    De Giorgi V; Zuccaro B; Silvestri F; Venturi F; Colombo J; Trane L
    Exp Oncol; 2023 Jun; 45(1):125-129. PubMed ID: 37417274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periocular lentigo maligna treated with imiquimod.
    O'Neill J; Ayers D; Kenealy J
    J Dermatolog Treat; 2011 Apr; 22(2):109-12. PubMed ID: 20666668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amelanotic lentigo maligna managed with topical imiquimod as immunotherapy.
    Powell AM; Russell-Jones R
    J Am Acad Dermatol; 2004 May; 50(5):792-6. PubMed ID: 15097969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentigo maligna successfully treated with imiquimod.
    du Plessis PJ
    S Afr J Surg; 2007 May; 45(2):72. PubMed ID: 17674567
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of lentigo maligna with imiquimod 5% cream.
    Hopson B; Richey D; Sajben FP
    J Drugs Dermatol; 2007 Oct; 6(10):1037-40. PubMed ID: 17966182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Imiquimod in the treatment of lentigo maligna].
    Nagore E; Botella-Estrada R
    Actas Dermosifiliogr; 2011 Oct; 102(8):559-62. PubMed ID: 21536245
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lentigo maligna treated with 5% imiquimod cream].
    Martín T; Ojeda A; Martínez S; Vera A
    Actas Dermosifiliogr; 2005 Dec; 96(10):700-2. PubMed ID: 16476324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imiquimod in the treatment of extensive recurrent lentigo maligna.
    Kamin A; Eigentler TK; Radny P; Bauer J; Weide B; Garbe C
    J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):51-2. PubMed ID: 15692515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of the off-label use of imiquimod, 5%, cream with vs without tazarotene, 0.1%, gel for the treatment of lentigo maligna, followed by conservative staged excisions.
    Hyde MA; Hadley ML; Tristani-Firouzi P; Goldgar D; Bowen GM
    Arch Dermatol; 2012 May; 148(5):592-6. PubMed ID: 22431716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world experience of off-label use of imiquimod 5% as an adjuvant therapy after surgery or as a monotherapy for lentigo maligna.
    Lallas A; Moscarella E; Kittler H; Longo C; Thomas L; Zalaudek I; Kyrgidis A; Manoli SM; di Meo N; Papageorgiou C; Apalla Z; Argenziano G
    Br J Dermatol; 2021 Sep; 185(3):675-677. PubMed ID: 33894006
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical Imiquimod for Management of Recurrent Lentigo Maligna Melanoma in Situ.
    Bartenjev MS; Isaković-Vidović S; Bartenjev I
    Acta Dermatovenerol Croat; 2020 Jul; 28(1):34-37. PubMed ID: 32650849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission of extensive lentigo maligna after treatment with imiquimod.
    Piazza CD; Sampaio SA
    An Bras Dermatol; 2009; 84(1):82-4. PubMed ID: 19377765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should topical imiquimod be used for positive margins in lentigo maligna?
    Wang TS; Griffiths CC; Roman EM
    J Am Acad Dermatol; 2021 Aug; 85(2):521-522. PubMed ID: 32387661
    [No Abstract]   [Full Text] [Related]  

  • 14. Lentigo maligna treated with topical imiquimod: dermatoscopy usefulness in clinical monitoring.
    Costa MC; Abraham LS; Barcaui C
    An Bras Dermatol; 2011; 86(4):792-4. PubMed ID: 21987152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of lentigo maligna with imiquimod before staged excision.
    Cotter MA; McKenna JK; Bowen GM
    Dermatol Surg; 2008 Feb; 34(2):147-51. PubMed ID: 18093206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and histologic features associated with lentigo maligna clearance after imiquimod treatment.
    Kwak R; Joyce C; Werchniak AE; Lin JY; Tsibris HC
    J Dermatolog Treat; 2022 Jun; 33(4):1995-1999. PubMed ID: 34315342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Reply to letter to the editor re: 'practical guide on the use of imiquimod cream to treat lentigo maligna'.
    Guitera P; Waddell A; Paton E; Fogarty GB; Hong A; Scolyer RA; Stretch JR; O'Donnell BA; Pellacani G
    Australas J Dermatol; 2022 May; 63(2):e198-e199. PubMed ID: 35107826
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of imiquimod cream, 5%, for lentigo maligna after complete excision: a study of 43 patients.
    Ly L; Kelly JW; O'Keefe R; Sutton T; Dowling JP; Swain S; Byrne M; Curr N; Wolfe R; Chamberlain A; Haskett M
    Arch Dermatol; 2011 Oct; 147(10):1191-5. PubMed ID: 22006136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Imiquimod treatment of lentigo maligna to dermoscopic and histologic clearance].
    Lorentzen HF; Weismann K
    Ugeskr Laeger; 2005 Sep; 167(39):3696-7. PubMed ID: 16219219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imiquimod: a novel treatment for lentigo maligna.
    Ahmed I; Berth-Jones J
    Br J Dermatol; 2000 Oct; 143(4):843-5. PubMed ID: 11069469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.